Coloplast Balance Sheet Health
Financial Health criteria checks 2/6
Coloplast has a total shareholder equity of DKK17.9B and total debt of DKK21.6B, which brings its debt-to-equity ratio to 120.6%. Its total assets and total liabilities are DKK48.1B and DKK30.1B respectively. Coloplast's EBIT is DKK7.3B making its interest coverage ratio 11.4. It has cash and short-term investments of DKK788.0M.
Key information
120.6%
Debt to equity ratio
DKK 21.64b
Debt
| Interest coverage ratio | 11.4x |
| Cash | DKK 788.00m |
| Equity | DKK 17.94b |
| Total liabilities | DKK 30.13b |
| Total assets | DKK 48.07b |
Recent financial health updates
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Recent updates
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?
Aug 22Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Financial Position Analysis
Short Term Liabilities: COLO B's short term assets (DKK10.4B) exceed its short term liabilities (DKK10.2B).
Long Term Liabilities: COLO B's short term assets (DKK10.4B) do not cover its long term liabilities (DKK19.9B).
Debt to Equity History and Analysis
Debt Level: COLO B's net debt to equity ratio (116.2%) is considered high.
Reducing Debt: COLO B's debt to equity ratio has increased from 15.4% to 120.6% over the past 5 years.
Debt Coverage: COLO B's debt is not well covered by operating cash flow (12.8%).
Interest Coverage: COLO B's interest payments on its debt are well covered by EBIT (11.4x coverage).